HUGO FRANCO: Open Payments
NPI 1629022769 · BELLE MEAD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 38 payments from 10 companies in 2025. Trend: 2023 $711 · 2024 $903 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $175 |
| Janssen Pharmaceuticals, Inc | 5 | $91 |
| Alkermes, Inc. | 4 | $78 |
| Neurocrine BioSciences, Inc. | 4 | $75 |
| Indivior Inc. | 4 | $70 |
| Bausch Health US, LLC | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Lundbeck LLC | 1 | $19 |
| Braeburn Inc. | 1 | $16 |
Products named: VRAYLAR, INVEGA SUSTENNA, INGREZZA, SUBLOCADE, VIVITROL, WELLBUTRIN, COBENFY, AUSTEDO XR.
Industry payments across NJ — which companies pay providers there.
